Emily Rollins - Mar 1, 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins
Stock symbol
DLB
Transactions as of
Mar 1, 2024
Transactions value $
-$80,880
Form type
4
Date filed
3/5/2024, 04:37 PM
Previous filing
Feb 29, 2024
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$80.9K -1K -11.77% $80.88 7.49K Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.